Adtalem Global Education Announces Second Quarter Fiscal Year 2025 Conference Call
02 Janeiro 2025 - 10:30AM
Business Wire
Adtalem Global Education Inc. (NYSE: ATGE), the leading
healthcare educator in the United States, announced today it will
release its second quarter fiscal year 2025 results on Thursday,
Jan. 30, 2025, after financial markets close, followed by a
conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to
discuss the results.
The call can be accessed by dialing +1 877-407-6184 (U.S.
participants) or +1 201-389-0877 (international participants) and
stating “Adtalem earnings call” or by using conference ID:
13750710. The call will be simulcast through the Adtalem investor
relations website at: https://investors.adtalem.com.
Adtalem will archive a replay of the call for 30 days. To access
the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415
(international), conference ID: 13750710, or visit the Adtalem
investor relations website.
About Adtalem Global Education
Adtalem Global Education is the leading provider of healthcare
education in the U.S., shaping the future of healthcare by
preparing a diverse workforce with high-quality academic programs.
We innovate education pathways, align with industry needs and
empower individuals to reach their full potential. Our commitment
to excellence and inclusivity is reflected in our expansive network
of institutions, serving over 90,000 students and supported by a
strong community of approximately 350,000 alumni and nearly 10,000
dedicated employees. Visit Adtalem.com for more information and
follow us on LinkedIn, Instagram and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250102271615/en/
Investor Contact Jay Spitzer
Investor.Relations@Adtalem.com +1 312-906-6600 Media Contact
Britt Mitchell AdtalemMedia@Adtalem.com +1 872-270-0301
Adtalem Global Education (NYSE:ATGE)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Adtalem Global Education (NYSE:ATGE)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025